Pilot study of recombinant human soluble tumor necrosis factor receptor (TNFR:Fc) in patients with low risk myelodysplastic syndrome
To access this article, please choose from the options below
PII: S0145-2126(01)00201-6
© 2002 Elsevier Science Ltd. All rights reserved.
